Circadian changes in the hemostatic system in healthy men and patients with cardiovascular diseases

Medical Science Monitor

Volumn 15, Issue 10, 2009, Pages

  Chrusciel, Piotr ^a   Goch, Aleksander ^a   Banach, Maciej ^b   Mikhailidis, Dimitri P ^c   Rysz, Jacek ^b   Goch, Jan Henryk ^b  

^a Department of Cardiology and Cardiac Surgery   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Circadian rhythm; Hemostasis; Platelets

Indexed keywords

BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CIRCADIAN RHYTHM; FIBRINOLYSIS; HEMOSTASIS; HUMAN; REVIEW; THROMBOCYTE AGGREGATION;

EID: 70349970942     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/msm.878203     Document Type: Review

References (83)

1. Muller JE, Stone PH, Turi ZG et al: MILIS Study Group: Circadian variation in the frequency of acute myocardial infarction. N Engl J Med, 1985; 313: 1315 (abstract)
2. Thompson DR, Sutton TW, Jowett NI, Pohl JE: Circadian variation in the frequency of onset of chest pain in acute myocardial infarction. Br Heart J, 1991; 65: 177-178
3. Tanaka A, Kawarabayashi T, Fukuda D et al: Circadian variation of plaque rupture in acute myocardial infarction. Am J Cardiol, 2004; 93: 1-5 (Pubitemid 38022024)
4. Hjalmarson A, Gilpin EA, Nicod P et al: Differing circadian patterns of symptom onset in subgroups of patients with acute myocardial infarction. Circulation, 1989; 80: 267-275 (Pubitemid 19195735)
5. Spielberg C, Falkenhahn D, Willich SN et al: Circadian, day-of-week, and seasonal variability in myocardial infarction: comparison between working and retired patients. Am Heart J, 1996; 132: 579-585 (Pubitemid 26347762)
6. Kono T, Morita H, Nishina T et al: Circadian variations of onset of acute myocardial infarction and efficacy of thrombolytic therapy. J Am Coll Cardiol, 1996; 27: 774-778 (Pubitemid 26104855)
7. Tofler GH, Muller JE, Stone PH et al: odifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group. J Am Coll Cardiol, 1992; 20: 1049-1055
8. Cannon CP, McCabe CH, Stone PH et al: Circadian variation in the onset of unstable angina and non-Q-wave myocardial infarction. Am J Cardiol, 1997; 79: 253-258
9. Kurnik PB: Circadian variation in the efficacy of tissue-type plasminogen activator. Circulation, 1995; 91: 1341-1346
10. Morning peak in the incidence of myocardial infarction: experience in the ISIS-2 trial. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Eur Heart J, 1992; 13: 594-598
11. Khan MS, Ahmad SI: Circadian variation - increased morning incidence of acute myocardial infarction in patients with coronary artery disease. J Pak Med Assoc, 2003; 53: 84-87
12. Sayer JW, Wilkinson P, Ranjadayalan K et al: Attenuation or absence of circadian and seasonal rhythms of acute myocardial infarction. Heart, 1997; 77: 325-329 (Pubitemid 27208171)
13. D'Negri CE, Nicola-Siri L, Vigo DE et al: Circadian analysis of myocardial infarction incidence in an Argentine and Uruguayan population. BMC Cardiovasc Disord, 2006; 6: 1 (Pubitemid 43103499)
14. Muller JE, Ludmer PL, Willich SN et al: Circadian variation in the frequency of sudden cardiac death. Circulation, 1987; 75: 131-138 (Pubitemid 17234550)
15. Martens PR, Calle P, Van den Poel B, Lewi P: Further prospective evidence of a circadian variation in the frequency of call for sudden cardiac death. Belgian Cardiopulmonary Cerebral Resuscitation Study Group. Intensive Care Med, 1995; 21(1): 45-49
16. Hayashi S, Toyoshima H, Tanabe N, Miyanishi K: Daily peaks in the incidence of sudden cardiac death and fatal stroke in Niigata Prefecture. Jpn Circ J, 1996; 60: 193-200 (Pubitemid 26185443)
17. Pepine CJ: Therapeutic implications of circadian variations in myocardial ischemia and related physiologic functions. Am J Hypertens, 1991; 4(7 Pt 2): 442S-48S
18. Rocco MB, Barry J, Campbell S et al: Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation, 1987; 75: 395-400 (Pubitemid 17007346)
19. Manfredini R, Boari B, Bressan S et al: Influence of circadian rhythm on mortality after myocardial infarction: data from a prospective cohort of emergency calls, Am J Emerg Med, 2004; 22: 555-559 (Pubitemid 40143236)
20. Reisin LH, Pancheva N, Berman M et al: Circadian variation of the efficacy of thrombolytic therapy in acute myocardial infarction-isn't the time ripe for cardiovascular chronotherapy? Angiology, 2004; 55: 257-263
21. Goldhammer E, Kharash L, Abinader EG: Circadian fluctuations in the efficacy of thrombolysis with streptokinase. Postgrad Med J, 1999; 75: 667-671 (Pubitemid 29495599)
22. Braunwald E: Morning resistance to thrombolytic therapy. Circulation 1995; 91: 1604-1606
23. Kurnik PB: Circadian variation in the efficacy of tissue-type plasminogen activator. Circulation, 1995; 91: 1341-1346
24. Kharash LM, Gol'dkhammer EI, Abinader EG: The clinical aspects of thrombolytic therapy with streptokinase in myocardial infarct. Ter Arkh, 1996; 68: 53-57
25. Zeymer U, Mateblowski M, Neuhaus KL: Recombinant hirudin (HBW 023) produces stable anticoagulation unaffected by circadian variation in patients with thrombolysis for acute myocardial infarction. Eur Heart J, 1996; 17: 1836-1840 (Pubitemid 26413916)
26. Sari I, Davutoglu V, Erer B et al: Analysis of circadian variation of acute myocardial infarction: afternoon predominance in Turkish population. Int J Clin Pract, 2009; 63: 82-86
27. Savopoulos C, Ziakas A, Hatzitolios A et al: Circadian rhythm in sudden cardiac death: a retrospective study of 2,665 cases. Angiology, 2006; 57: 197-204 (Pubitemid 44438572)
28. López F, Lee KW, Marín F et al: Are there ethnic differences in the circadian variation in onset of acute myocardial infarction? A comparison of 3 ethnic groups in Birmingham, UK and Alicante, Spain. Int J Cardiol, 2005; 100: 151-154 (Pubitemid 40487949)
29. Fava S, Azzopardi J, Muscat HA, Fenech FF: Absence of circadian variation in the onset of acute myocardial infarction in diabetic subjects. Br Heart J, 1995; 74: 370-372
30. Ridker PM, Manson JE, Buring JE et al: Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians. Circulation, 1990; 82: 897-902
31. Rudnicka AR, Rumley A, Lowe GD, Strachan DP: Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation, 2007; 115: 996-1003 (Pubitemid 46328293)
32. Bridges AB, McLaren M, Saniabadi A et al: Circadian variation of endothelial cell function, red blood cell deformability and dehydro-thromboxane B2 in healthy volunteers. Blood Coagul Fibrinolysis, 1991; 2: 447-452
33. Bridges AB, McLaren M, Scott NA et al: Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease. Br Heart J, 1993; 69: 121-124 (Pubitemid 23056850)
34. Sayer JW, Gutteridge C, Syndercombe-Court D et al: Circadian activity of the endogenous fibrinolytic system in stable coronary artery disease: effects of beta-adrenoreceptor blockers and angiotensin-converting enzyme inhibitors. J Am Coll Cardiol, 1998; 32: 1962-1968 (Pubitemid 29010462)
35. Osmancik P, Kvasnicka J, Widimsky P, Tarnok A: Diurnal variation of soluble E- and P-selectin, and intercellular adhesion molecule-1 in patients with and without coronary artery disease. Cardiology, 2004; 102: 194-199 (Pubitemid 39370533)
36. Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP: Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost, 2003; 9: 177-190
37. Maple C, Kirk G, McLaren M et al: A circadian variation exists for soluble levels of intercellular adhesion molecule-1 and E-selectin in healthy volunteers. Clin Sci (Lond), 1998; 94: 537-540 (Pubitemid 28205920)
38. Madden L, Vince R, Sandström M et al: Microparticle-associated vascular adhesion molecule-1 and tissue factor follow a circadian rhythm in healthy human subjects. Thromb Haemost, 2008; 99: 909-915 (Pubitemid 351705308)
39. Mikhailidis DP, Barradas MA, Maris A et al: Fibrinogen-mediated activation of platelet aggregation and thromboxane A2 release: pathological implications in vascular disease. J Clin Pathol, 1985; 38: 1166-1171 (Pubitemid 16233391)
40. Undar L, Türkay C, Korkmaz L: Circadian variation in circulating platelet aggregates. Ann Med, 1989; 21: 429 (Pubitemid 20029328)
41. Tofler GH, Brezinski D, Schager AI et al: Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med, 1987; 316: 1514-1518 (Pubitemid 17076236)
42. Jafri SM, VanRollins M, Ozawa T et al: Circadian variation in platelet function in healthy volunteers. Am J Cardiol, 1992; 69: 951-954
43. Undar L, Ertugrul C, Altunbas H, Akca S: Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6. Thromb Haemost, 1999; 81: 571-575 (Pubitemid 29178943)
44. Kanabrocki EL, Sothern RB, Messmore HL et al: Circadian interrelationships among levels of plasma fibrinogen, blood platelets, and serum interleukin-6. Clin Appl Thromb Hemost, 1999; 5: 37-42
45. Pechán J, Mikulecký M, Okrucká A: Circadian rhythm of plasma beta-thromboglobulin in healthy human subjects. Blood Coagul Fibrinolysis, 1992; 3: 105-107
46. Ogawa H, Yasue H, Oshima S et al: Circadian variation of plasma fibrinopeptide A level in patients with variant angina. Circulation, 1989; 80: 1617-1626 (Pubitemid 20031691)
47. Someya N, Morotomi Y, Kodama K et al: Suppressive effect of captopril on platelet aggregation in essential hypertension. J Cardiovasc Pharmacol, 1984; 6: 840-843 (Pubitemid 14023335)
48. James IM, Dickenson EJ, Burgoyne W et al: Treatment of hypertension with captopril: preservation of regional blood flow and reduced platelet aggregation. J Hum Hypertens, 1988; 2: 21-25 (Pubitemid 18156809)
49. Tison P, Ulicna L, Jakubovska Z et al: Effects of dihydropyridines and their combination with aspirin on blood pressure and circadian platelet activity in patients with essential hypertension. Am J Hypertens, 1994; 7(7 Pt 2): 46S-49S (Pubitemid 24248715)
50. Larsson PT, Wallén NH, Martinsson A et al: Significance of platelet beta-adrenoceptors for platelet responses in vivo and in vitro. Haemost, 1992; 68: 687-693
51. Levine SP, Towell BL, Suarez AM et al: Platelet activation and secretion associated with emotional stress. Circulation, 1985; 71: 1129-1134
52. Ding YA, Chou TC, Lin KC: Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension. J Hum Hypertens, 1994; 8: 273-278
53. Tison P, Ulicna L, Jakubovska Z et al: Effects of dihydropyridines and their combination with aspirin on blood pressure and circadian platelet activity in patients with essential hypertension. Am J Hypertens, 1994; 7(7 Pt 2): 46S-49S (Pubitemid 24248715)
54. Fetkovska N, Jakubovska Z, Oravcova J et al: Treatment of hypertension with calcium antagonists and aspirin. Effects on 24-h platelet activity. Am J Hypertens, 1993; 6(3 Pt 2): 98S-101S (Pubitemid 23114920)
55. 1+2, and Plasmin-Plasmin Inhibitor Complex. Circulation, 1997; 96: 19-21
56. Pinotti M, Bertolucci C, Portaluppi F et al: Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity. Arterioscler Thromb Vasc Biol, 2005; 25: 646-649 (Pubitemid 40315692)
57. Misumi K, Ogawa H, Yasue H et al: Circadian variation in plasma levels of free-form tissue factor pathway inhibitor antigen in patients with coronary spastic angina. Jpn Circ J, 1998; 62: 419-424 (Pubitemid 28257459)
58. Sothern RB, Roitman-Johnson B, Kanabrocki EL et al: Circadian characteristics of circulating interleukin-6 in men. J Allergy Clin Immunol, 1995; 95: 1029-1035
59. Gerbig AW, Dahinden CA, Mullis P, Hunziker T: Circadian elevation of IL-6 levels in Muckle-Wells syndrome: a disorder of the neuroimmune axis? QJM, 1998; 91: 489-492
60. Bremner WF, Sothern RB, Kanabrocki EL et al: Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men. Am Heart J, 2000; 139: 164-173
61. Späth-Schwalbe E, Hansen K, Schmidt F et al: Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab, 1998; 83: 1573-1579 (Pubitemid 28501024)
62. van Gameren MM, Willemse PH, Mulder NH et al: Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study. Blood, 1994; 84: 1434-1441 (Pubitemid 24273010)
63. Kushner I, Broder ML, Karp D: Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest, 1978; 61: 235-242 (Pubitemid 8280392)
64. Meier-Ewert HK, Ridker PM, Rifai N et al: Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem, 2001; 47: 426-430 (Pubitemid 32222455)
65. Angleton P, Chandler WL, Schmer G: Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation, 1989; 79: 101-106
66. Huber K, Rosc D, Resch I et al: Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction. Thromb Haemost, 1988; 60: 372-376 (Pubitemid 19023725)
67. Rosenfeld BA, Faraday N, Campbell D et al: The effects of bedrest on circadian changes in hemostasis. Thromb Haemost, 1994; 72: 281-284 (Pubitemid 24251294)
68. van Diest R, Hamulyák K, Kop WJ et al: Diurnal Variations in Coagulation and Fibrinolysis in Vital Exhaustion PHD. Psychosom Med, 2002; 64: 787-792
69. Iversen PO, Groot PD, Hjeltnes N et al: Impaired circadian variations of haemostatic and fibrinolytic parameters in tetraplegia. Br J Haematol, 2002; 119: 1011-1016 (Pubitemid 35463827)
70. Johansen LG, Gram J, Kluft C, Jespersen J: Chronobiology of coronary risk markers in Greenland Eskimos: a comparative study with Caucasians residing in the same Arctic area. Chronobiol Int, 1991; 8: 352-360
71. Haus E: Chronobiology of hemostasis and inferences for the chronotherapy of coagulation disorders and thrombosis prevention. Adv Drug Deliv Rev, 2007; 59: 966-984
72. Woodhouse PR, Khaw KT, Plummer M et al: Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet, 1994; 343(8895): 435-439 (Pubitemid 24059584)
73. Mercer JB, Osterud B, Tveita T: The effect of short-term cold exposure on risk factors for cardiovascular disease. Thromb Res, 1999; 95: 93-104 (Pubitemid 29349723)
74. Lip GY, Edmunds E, Hee FL et al: A cross-sectional, diurnal, and followup study of platelet activation and endothelial dysfunction in malignant phase hypertension. Am J Hypertens, 2001; 14(8 Pt 1): 823-828 (Pubitemid 32682252)
75. Li-Saw-Hee FL, Blann AD, Lip GY: A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation. J Am Coll Cardiol, 2000; 35: 1926-1931 (Pubitemid 30342877)
76. Peverill RE, Smolich JJ: Diurnal rhythms and hemostatic factors in atrial fibrillation. J Am Coll Cardiol, 2001; 37: 969-971
77. Goch A, Banach M, Mikhailidis DP, Goch JH: Endothelial dysfunction in patients with non-complicated and complicated hypertension. Clin Exp Hypertens, 2009; 31: 20-30
78. Kakafika AI, Liberopoulos EN, Mikhailidis DP: Fibrinogen: a predictor of vascular disease. Curr Pharm Des, 2007; 13: 1647-1659
79. Kowalski J, Banach M, Barylski M et al: Carvedilol modifies antioxidant status of patients with stable angina. Cell Mol Biol Lett, 2008; 13: 230-239
80. Barylski M, Kowalczyk E, Banach M et al: Plasma total antioxidant activity in comparison with plasma NO and VEGF levels in patients with metabolic syndrome. Angiology, 2009; 60: 87-92
81. Karagiannis A, Tziomalos K, Mikhailidis DP et al: Seasonal variation in the occurrence of stroke in Northern Greece: a 10 year study in 8204 patients. Neurol Res, 2009; (in press)
82. Irzmanski R, Barylski M, Banach M et al: The concentration of atrial and brain natriuretic peptide in patients with idiopathic arterial hypertension. Med Sci Monit, 2007; 13(10): CR449-56 (Pubitemid 350013897)
83. Barylski M, Banach M, Mikhailidis DP et al: Decreased kidney function as a risk factor for cardiovascular events in subjects with metabolic syndrome - a pilot study. Arch Med Sci, 2008; 4: 417-423